| Dr Barbara Gertrud Friederike Hoene, MD | |
|
281 Mast Rd, Durham, NH 03824-4712 | |
| (603) 868-7075 | |
| (603) 868-7075 |
| Full Name | Dr Barbara Gertrud Friederike Hoene |
|---|---|
| Gender | Female |
| Speciality | Specialist |
| Location | 281 Mast Rd, Durham, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801943410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 48316 (Massachusetts) | Primary |
| 174400000X | Specialist | 48316 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barbara Gertrud Friederike Hoene, MD 281 Mast Rd, Durham, NH 03824-4712 Ph: (603) 868-7075 | Dr Barbara Gertrud Friederike Hoene, MD 281 Mast Rd, Durham, NH 03824-4712 Ph: (603) 868-7075 |
News Archive
Archimedes Inc., a healthcare modeling company, today announced the launch of a new web interface, ARCHeS Innovator, which will give health experts direct access to many of the features of the Archimedes Model.
"In the face of mounting Republican opposition to its healthcare agenda, the Obama administration received a boost Wednesday, winning a preliminary agreement with leading hospital groups to cut federal payments to the industry over the next decade," The Los Angeles Times reports.
A higher dose of radiation (74 Gy) does not improve overall survival for non-small cell lung cancer that has spread to the lymph nodes, compared to the standard radiation dose (60 Gy), according to an interim analysis of a late-breaking randomized study presented at the plenary session, October 3, 2011, at the 53rdAnnual Meeting of the American Society for Radiation Oncology.
New sensor systems being developed will help treat cancer and improve the accuracy and reliability of existing radiation treatments. They should help improve patient care and outcomes. The results will go straight to commercialisation when finalised next year.
Rep. Charles Rangel, D-N.Y., says the House Ways and Means Committee may seek to raise money for health reform by imposing a $37 billion tax on drugmaker's advertisements, Bloomberg reports: "As lawmakers seek ways to pay for a health-care overhaul, 'one thing that's not off the table is you can pick up $37 billion knocking out the deduction for advertising' for prescription drugs,'" Rangel said. The idea is among several proposals by Democratic legislators to raise reform money (Donmoyer, 6/16).
› Verified 8 days ago